Zobrazeno 1 - 10
of 93
pro vyhledávání: '"A C, van Grootheest"'
Publikováno v:
Bijblijven. 24:17-24
De kern van goede farmacotherapie is het voortdurend afwegen van te behalen voordeel ten opzichte van de mogelijke risico’s. De systematische aandacht voor bijwerkingen van geneesmiddelen valt in Nederland onder de regie van het in de jaren zestig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7deb2f412cd276d0b4c4ee9315401a34
https://doi.org/10.1007/bf03076352
https://doi.org/10.1007/bf03076352
Publikováno v:
Bijblijven. 24:25-31
Hoe kan de huisarts bepalen of er inderdaad sprake is van een bijwerking, en wat betekent dit voor het toekomstige farmacologische beleid? In dit artikel worden de achtergronden van het ontstaan van bijwerkingen beschreven en gaan we in op de wijze w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a642873752e20728d2cd58f7b2ee8228
https://doi.org/10.1007/bf03076353
https://doi.org/10.1007/bf03076353
Publikováno v:
Drug Safety. 30:919-990
Introduction: Thiazolidine derivatives, i.e pioglitazone and rosiglitazone are used in type 2 diabetes mellitus treatment. Thiazolidinediones are selective agonists at the peroxisome proliferator activated receptor gamma (PPARγ) which is present in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6bdb52362626ba199b7cf930c1a6dab
https://doi.org/10.2165/00002018-200730100-00138
https://doi.org/10.2165/00002018-200730100-00138
Publikováno v:
Drug Safety. 30:919-990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec784e7a8ffab55064ac4809fb67b29e
https://doi.org/10.2165/00002018-200730100-00127
https://doi.org/10.2165/00002018-200730100-00127
Publikováno v:
Drug Safety. 30:919-990
Results: Delayed adaptability to darkness, characterised as a delay in recovering visual function after bright illumination (sun, bright light), is the most frequent adverse effect in patients with prostatic carcinoma receiving nilutamide alone or in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::653b89fd30bf6b3dbc77a5c42ec8e2ce
https://doi.org/10.2165/00002018-200730100-00076
https://doi.org/10.2165/00002018-200730100-00076
Publikováno v:
Drug Safety. 30:919-990
Background In August 2006, the Netherlands Pharmacovigilance Centre Lareb started with Lareb Intensive Monitoring (LIM). The main objective of LIM is to monitor the safety of new drugs. Patients eligible for participation are identified using the fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54ca434d222c7853e057b6394adff432
https://doi.org/10.2165/00002018-200730100-00112
https://doi.org/10.2165/00002018-200730100-00112
Publikováno v:
Drug Safety. 30:919-990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4986a62b6c8c883ae9c06dbab8dbb293
https://doi.org/10.2165/00002018-200730100-00077
https://doi.org/10.2165/00002018-200730100-00077
Publikováno v:
Drug Safety. 29:911-1010
Aripiprazole has a higher affinity for D2-receptors than dopamine itself. If aripiprazole has bond, dopamine won’t be capable of binding to these receptors. As a consequence, in areas with a lot of dopamine activity aripiprazole works as a relative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ff500e41a7c83a2da3051547f4158e1
https://doi.org/10.2165/00002018-200629100-00029
https://doi.org/10.2165/00002018-200629100-00029
Publikováno v:
Drug Safety. 29:911-1010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f10f844f38cdcbb847a292588f85214
https://doi.org/10.2165/00002018-200629100-00166
https://doi.org/10.2165/00002018-200629100-00166
Publikováno v:
Drug Safety. 29:911-1010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f340bdd822edabba03dfa191bb8027e
https://doi.org/10.2165/00002018-200629100-00178
https://doi.org/10.2165/00002018-200629100-00178